The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.
April 28th 2025
Dostarlimab in the neoadjuvant setting yielded a 100% clinical complete response in patients with rectal cancer.
FDA Approves First Targeted Therapy for Subset of Non-Small Cell Lung Cancer
May 21st 2021In a trial of amivantamab-vmjw, investigators found an overall response rate of 40% among patients with non-small cell lung cancer whose tumors have epidermal growth factor receptor exon 20 insertion mutations.
Read More
An Overview of ALS Treatment Developments for ALS Awareness Month
May 19th 2021Matthew Harms, a medical consultant and care center director at the MDA and associate professor of neurology at Columbia University Medical Center, to discuss new treatments and anticipated developments for ALS over the next year.
Watch
Combination Immunotherapy Provides Potential Benefits in Controlling, Reducing HIV
May 19th 2021A combination immunotherapy of interleukin-21 (IL-21) and interferon alpha (IFN-alpha) in combination with antiretroviral therapy (ART) is effective in generating highly functional natural killer (NK) cells that can help control and reduce simian immunodeficiency virus (SIV) in animal models.
Read More
ASHP: Residency Match Program Continues to Grow Despite Pandemic Challenges
May 14th 2021The American Society of Health-System Pharmacists' (ASHP) Pharmacy Residency Match program continued its growth trend with nearly 5500 pharmacy students and residents paired with residency positions in 2021.
Read More